Literature DB >> 11268379

Role of cyclophilins in somatolactogenic action.

M A Rycyzyn1, C V Clevenger.   

Abstract

Prolactin (PRL) and growth hormone (GH) are members of the somatolactogenic hormone family, the pleiotropic actions of which are necessary for vertebrate growth and mammary differentiation. The basis for the specific function of these hormones has remained uncertain; however, their action is associated with internalization and translocation into the nucleus. A yeast two-hybrid screen identified an interaction between PRL and cyclophilin B (CypB), a peptidyl prolyl isomerase (PPI) found in the endoplasmic reticulum (ER), extracellular space, and nucleus. The interaction between CypB and PRL/GH was confirmed in vitro and in vivo through the use of recombinant proteins and coimmunoprecipitation studies. The exogenous addition of CypB potentiated the proliferation of PRL- and GH-dependent cell lines 18- and 40-fold, respectively. The potentiation of PRL action by CypB was accompanied by a dramatic increase in the nuclear retrotranslocation of PRL. Immunogold electron microscopy has revealed this retrotransport to occur via a vesicular pathway. A CypB mutant, termed CypB-NT, was generated that lacked the putative wild-type N-terminal nuclear localization sequence. Although CypB-NT demonstrated levels of PRL binding and PPI activity equivalent to wild-type CypB, it was incapable of mediating the nuclear retrotranslocation of PRL or enhancing PRL-driven proliferation. These studies reveal CypB as an important chaperone facilitating the nuclear retrotransport and action of the somatolactogenic hormone family.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11268379     DOI: 10.1111/j.1749-6632.2000.tb05416.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  4 in total

1.  A novel and functional interaction between cyclophilin A and prolactin receptor.

Authors:  Farhat Syed; Michael A Rycyzyn; Liz Westgate; Charles V Clevenger
Journal:  Endocrine       Date:  2003 Feb-Mar       Impact factor: 3.633

2.  The isolation of novel mesenchymal stromal cell chemotactic factors from the conditioned medium of tumor cells.

Authors:  Siang-Yo Lin; Jun Yang; Allen D Everett; Charles V Clevenger; Mythili Koneru; Pravin J Mishra; Barton Kamen; Debabrata Banerjee; John Glod
Journal:  Exp Cell Res       Date:  2008-08-08       Impact factor: 3.905

Review 3.  From bench to bedside: future potential for the translation of prolactin inhibitors as breast cancer therapeutics.

Authors:  Charles V Clevenger; Jiamao Zheng; Elizabeth M Jablonski; Traci L Galbaugh; Feng Fang
Journal:  J Mammary Gland Biol Neoplasia       Date:  2008-02-02       Impact factor: 2.673

Review 4.  Cyclophilin nomenclature problems, or, 'a visit from the sequence police'.

Authors:  Daniel W Nebert; Nickolas A Sophos; Vasilis Vasiliou; David R Nelson
Journal:  Hum Genomics       Date:  2004-08       Impact factor: 4.639

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.